NMR investigations of duplex stability of phosphorothioate and
phosphorodithioate DNA analogues modified in both strands
NMR investigations of duplex stability of phosphorothioate and phosphorodithioate DNA analogues modified in both strands
Jerzy W.
Jaroszewski*
,
Vicki
Clausen
,
Jack S.
Cohen
1
and
Otto
Dahl
2
Department of Medicinal Chemistry, Royal Danish School of Pharmacy,
Universitetsparken 2, DK-2100
Copenhagen
,
Denmark
,
1
Department of Pharmacology, Georgetown University Medical Center,
Washington,
DC
20007,
USA
and
2
Department of Chemistry, The H. C. Ørsted Institute, University of Copenhagen, Universitetsparken 5, DK-2100
Copenhagen
,
Denmark
Received December 12, 1995;
Revised and Accepted January 23, 1996
ABSTRACT
Duplex formation from the self-complementary 12mer d(CGCGAATTCGCG)
(Dickerson dodecamer) in which all phosphodiester linkages were replaced by
phosphorothioate or phosphorodithioate linkages was studied using variable-temperature
1
H and
31
P NMR spectroscopy. Melting temperatures of the dodecamer, measured
spectrophotometrically, showed significant decrease upon sulfur substitution (
T
m 49
o
C for the phosphorothioate and 21
o
C for the phosphorodithioate, compared with 68
o
C for the unmodified oligomer, in 1 M salt). Hyperchromicity observed upon
melting of the dithioate was surprisingly low. NOESY spectra of the monothioate
showed a cross-peak pattern characteristic for a right-handed duplex. Imino proton resonances of the duplex, shown by the
mono- and the dithioate, were similar to those of the parent compound. In spite
of monophasic melting curves, temperature dependence of the imino proton
resonances and phosphorus resonances of the phosphorodithioate indicated
heterogeneity with respect to base-pairing, compatible with the presence of a hairpin loop. Relaxation times
(
T
1) of the imino protons in the phosphorothioate, determined by the saturation
recovery method, were considerably shorter than in the unmodified oligomer.
Base-pair lifetimes in the unmodified Dickerson dodecamer, determined by
catalyst-dependent changes in relaxation rates of imino protons, were in the range
of 2-30 ms at 20
o
C. Strongly reduced base-pair lifetimes were found in the phosphorothioate analogue.
INTRODUCTION
Synthetic DNA analogues with non-bridging oxygen atoms of the phosphodiester group replaced by sulfur
(phosphorothioates and phosphorodithioates) are of great importance as
biochemical and pharmacological tools (
1
-
4
). They have the important property of being resistant to most hydrolytic
enzymes, and thus can persist in biological environment such as the interior of
a cell. Phosphorothioates are the most easily prepared and widely used type of
chemically modified DNA. Phosphorodithioates have been synthesized only
recently (
5
-
8
), and their availability and use is still restricted. Previous studies have
established the ability of both analogues to form stable duplexes with native
DNA and RNA, and to inhibit RNA translation, although the heteroduplexes had
somewhat diminished melting temperatures (
9
,
10
).
Although the formation of B-type duplexes between native DNA and the sulfur-containing analogues is widely assumed, only little is known about
the effects of sulfur substitution on duplex stability and geometry (
11
-
13
), apart from what can be concluded from analysis of melting curves. A self-complementary decamer which forms a stable B-type duplex as unmodified DNA changed to a hairpin when one or two
central phosphorodithioate sites were introduced, and A-type structures were observed (
8
,
14
,
15
). Theoretical investigations of phosphorothioates identified destabilizing
interactions depending on the stereochemistry of the phosphate group (
13
). Thus, the R
p
configuration of the chiral phosphorothioate group, in which sulfur points into
the major groove, is helix-destabilizing, whereas the S
p
configuration, in which sulfur points outwards, is not (
13
), in agreement with NMR detectable changes observed in B-DNA upon stereospecific substitution with sulfur at a single site (
12
). In this work, we applied various NMR techniques to obtain additional
information about structure and stability of oligodeoxynucleotide duplexes
modified in both strands. In particular, properties of the exchangeable
hydrogens (imino protons) were of interest. The imino protons are especially
suitable for studies of phosphorothioates, which are prepared and used as
heterogeneous mixtures of R
p
and S
p
diastereomers, because the change of stereochemistry at phosphorus has
relatively little effect on the chemical shifts of the imino protons. The
Dickerson dodecamer (Fig.
1
), a prototype B-DNA sequence, was used.
MATERIALS AND METHODS
The unmodified dodecamer (
I
) was synthesized by standard cyanoethylphosphoramidite method on an Applied
Biosystems Model 394 DNA synthesizer, purified as the tritylated derivative by
reverse-phase HPLC on a PRP-1 column eluted with a 0.1 M triethylammonium acetate buffer with an
acetonitrile gradient, detritylated, and precipitated with ethanol as the
sodium salt. The phosphorothioate (
II
) was obtained using 3
H
-1,2-benzodithiol-3-one 1,1-dioxide in acetonitrile as the sulfurization
reagent (
16
) and purified similarly (the material obtained consisted of a mixture of
stereoisomers with respect to the chiral phosphorothioate groups). The
dithioate (
III
) was obtained by the thiophosphoramidite method and purified as previously
described (
6
); according to a
31
P NMR spectrum the preparation contained 8% of monothioates.
NMR spectra were obtained on a Bruker AMX 400 WB spectrometer in 5 mm tubes.
Concentrations of (
I
), (
II
) and (
III
) were 2.5, 1.9 and 0.9 mM respectively (single strand), in 10 mM phosphate
buffer containing 0.1 or 1 M NaCl and 1 mM EDTA, pH ~7. The solvent was either D
2
O or H
2
O/D
2
O 9:1. In the latter solvent, exchangeable protons were observed by means of a 1
3
3
1
pulse (
17
), for the relaxation rate measurements preceded by a low-power selective saturation pulse and a variable delay.
1
H NMR spectra were standardized by means of sodium 3-(trimethylsilyl)propanesulfonate.
31
P NMR spectra were obtained with WALTZ16 decoupling of protons and standardized
to external conc. phosphoric acid. NOESY spectra were obtained with sweep
widths in both dimensions of 4000 Hz and a data matrix of 1024 * 512 points, zero-filled to 1k * 1k points prior to transformation. Measurements of pH were
carried out with a microelectrode directly in the NMR tubes.
Concentrations of oligonucleotides were measured spectrophotometrically with a
Shimadzu-265 spectrophotometer at 256-258 nm, assuming standard values of absorptivity for purines and
pyrimidines (respectively 14 000 and 7000 l * mol
-1
* cm
-1
). Melting curves were determined at 1 M ionic strength (10 mM phosphate buffer,
1 M NaCl, 1 mM EDTA, pH 7.2), after initial heating to 90oC and cooling to 0-20oC with a Gilford Response II spectrophotometer, using
temperature intervals of 0.5oC; the concentrations of oligodeoxynucleotides were 8-11 [mu]M (single strand).
RESULTS AND DISCUSSION
Melting temperatures (
T
m
) of (
I
), (
II
) and (
III
) were determined spectrophotometrically in 1 M salt as 68 (
18
),
49 and 21oC respectively (Fig.
2
). The melting of (
III
) was also followed by temperature dependence of NMR chemical shifts of non-exchangeable protons (Fig.
2
). The
T
m
values indicated a steady decrease of the duplex stability from (
I
) to (
III
), in agreement with previous results for monothioates (
9
) and for oligomers containing one dithioate strand (
6
,
10
). The optical hyperchromicity observed upon melting of (
III
) was much lower not only compared with (
II
) (Fig.
2
), but also to the previously studied (
6
,
10
) heteroduplexes. As described below, this behaviour is presumably due to the
presence of multiple structures in the solution of (
III
).
ACKNOWLEDGEMENTS
NMR equipment used in this work was made available by grants from the Alfred
Benzon Foundation and PharmaBiotec Research Center.
REFERENCES
1 Cohen, J. S. (1993) In Crooke, S. T. and Lebleu, B. (eds), Antisense Research and Applications. CRC Press, Boca Raton, pp. 205-221.
2 Cazenave, C. and Hélène, C. (1991) In Mol, J. N. M. and van der Krol, A. R. (eds) Antisense Nucleic Acids and Proteins. Marcel Dekker, New York, pp. 47-95.
3 Uhlmann, E. and Peyman, A. (1990) Chem. Rev., 90, 543-584.
4 Stein, C. A. and Cohen, J. S. (1989) In Cohen, J. S. (ed.) Oligodeoxynucleotides, Antisense Inhibitors of Gene Expression. MacMillan, London, pp. 97-117.
5 Nielsen, J., Brill, W. K.-D. and Caruthers, M. H. (1988) Tetrahedron Lett., 29, 2911-2914.
6 Bjergårde, K. and Dahl, O. (1991) Nucleic Acids Res., 19, 5843-5850.MEDLINE Abstract
7 Beaton, G., Brill, W. K.-D., Grandas, A., Ma, Y.-X., Nielsen, J., Yau, E. and Caruthers, M. H. (1991) Tetrahedron, 47, 2377-2388.
8 Piotto, M. E., Granger, J. N., Cho, Y., Farschtschi, N. and Gorenstein, D. G. (1991) Tetrahedron, 47, 2449-2461.
9 Stein, C. A., Subasinghe, C., Shinozuka, K. and Cohen, J. S. (1988) Nucleic Acids Res., 16, 3209-3221.MEDLINE Abstract
10 Ghosh, M. K., Ghosh, K., Dahl, O. and Cohen, J. S. (1993) Nucleic Acids Res., 21, 5761-5766.MEDLINE Abstract
11 Cruse, W. B. T., Salisbury, S. A., Brown, T., Cosstick, R., Eckstein, F. and Kennard, O. (1986) J. Mol. Biol., 192, 891-905.MEDLINE Abstract
12 LaPlanche, L. A., James, T. L., Powell, C., Wilson, W. D., Uznanski, B., Stec, W., Summers, M. F. and Zon, G. (1986) Nucleic Acids. Res., 14, 9081-9092.MEDLINE Abstract
13 Jaroszewski, J. W., Syi, J.-L., Maizel, J. and Cohen, J. S. (1992) Anti-Cancer Drug. Des., 7, 253-262.
14 Piotto, M. E., Granger, J. N., Cho, Y. and Gorenstein, D. G. (1990) J. Am. Chem. Soc., 112, 8632-8634.
15 Cho, Y., Luxon, B. A. and Gorenstein, D. G. (1993) J. Biomol. Struct. Dyn., 11, 685-702.MEDLINE Abstract
16 Iyer, R. P., Egan, W., Regan, J. B. and Beaucage, S. L. (1990) J. Am. Chem. Soc., 112, 1253-1254.
18 Patel, D. J., Kozlowski, S. A., Marky, L. A., Broka, C., Rice, J. A., Itakura, K. and Breslauer, K. J. (1982) Biochemistry, 21, 428-436.MEDLINE Abstract
19 Hare, D. R., Wemmer, D. E., Chou, S.-H., Drobny, G. and Reid, B. R. (1983) J. Mol. Biol., 171, 319-336.MEDLINE Abstract
20 Ott, J. and Eckstein, F. (1985) Biochemistry, 24, 2530-2535.
21 Lycksell, P.-O., Gräslund, A., Claesens, F., McLaughlin, L. W., Larsson, U. and Rigler, R. (1987) Nucleic Acids Res., 15, 9011-9025.MEDLINE Abstract
22 Sklenar, V. and Bax, A. (1987) J. Am. Chem. Soc., 109, 7525-7526.
23 Moe, J. G. and Russu, I. M. (1990) Nucleic Acids Res., 18, 821-827.MEDLINE Abstract
24 Moe, J. G. and Russu, I. M. (1992) Biochemistry, 31, 8421-8428.MEDLINE Abstract
25 Leijon, M. and Gräslund, A. (1992) Nucleic Acids Res., 20, 5339-5343.MEDLINE Abstract
26 Wemmer, D. E., Chou, S. H. and Reid, B. R. (1985) Nucleic Acids Res., 13, 468-476.
27 Roy, S., Weinstein, S., Borah, B., Nickol, J., Appella, E., Sussman, J. L., Miller, M., Shindo, H. and Cohen, J. S. (1986) Biochemistry,25, 7417-7423.MEDLINE Abstract
28 Roy, S., Sklenar, V., Appella, E. and Cohen, J. S. (1987) Biopolymers,26, 2041-2052.
29 Ikuta, S., Chattopadhyaya, R., Ito, H., Dickerson, R. E. and Kearns, D. R. (1986) Biochemistry, 25, 4840-4849.MEDLINE Abstract
30 Williamson, J. R. and Boxer, S. G. (1989) Biochemistry, 28, 2819-2831.MEDLINE Abstract
31 Marky, L. A., Blumenfeld, K. S., Kozlowski, S. and Breslauer, K. J. (1983) Biopolymers, 22, 1247-1257.
32 Glick, G. D., Osborne, S. E., Knitt, D. S. and Marino, J. P. Jr (1992) J. Am. Chem. Soc., 114, 5447-5448.
33 Pardi, A., Morden, K. M., Patel, D. J. and Tinoco, I. Jr (1982) Biochemistry,21, 6567-6574.MEDLINE Abstract
34 Patel, D. J., Ikuta, S., Kozlowski, S. and Itakura, K. (1983) Proc. Natl Acad. Sci. USA,80, 2184-2188.MEDLINE Abstract
35 Johnston, P. D. and Redfield, A. G. (1981) Biochemistry,20, 3996-4006.MEDLINE Abstract
36 Leroy, J. L., Kochoyan, M., Huynh-Dinh, T. and Guéron, M. (1988) J. Mol. Biol., 200, 223-238.MEDLINE Abstract
37 Stec, W. J., Grajkowski, A., Koziolkiewicz, M. and Uznanski, B. (1991) Nucleic Acids Res., 19, 5883-5888.MEDLINE Abstract
38 Gao, H., Chidambaram, N., Chen, B. C., Pelham, D. E., Patel, R., Yang, M., Zhou, L., Cook, A. and Cohen, J. S. (1994) Bioconjugate Chem., 5, 445-453.